Aktis Oncology, Inc. Common stock (AKTS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for AKTS were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0002035832 (2026-04-11) ↗